Skip to content
10-Q

Quarterly Report

BIOTRICITY INC. BTCY

0001493152-25-023361

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2026 · Nov 13, 2025 27.8M sh
Shares Diluted Q2 2026 · Sep 30, 2025 26.77M sh
Shares Diluted Q2 2026 · Sep 30, 2025 26.77M sh
Shares Diluted Q2 2026 · Sep 30, 2024 22.49M sh
Shares Diluted Q2 2026 · Sep 30, 2024 18.35M sh
Operating Cash Flow Q2 2026 · Sep 30, 2025 $42.24K
Operating Cash Flow Q2 2026 · Sep 30, 2024 −$1.89M
Cash And Equivalents Q2 2026 · Sep 30, 2025 $308.46K
Cash And Equivalents Q2 2026 · Mar 31, 2025 $365.15K
Stockholders Equity Q2 2026 · Sep 30, 2025 −$33.41M
Stockholders Equity Q2 2026 · Jun 30, 2025 −$32.8M
Stockholders Equity Q2 2026 · Mar 31, 2025 −$32.01M
Stockholders Equity Q2 2026 · Sep 30, 2024 −$31.17M
Stockholders Equity Q2 2026 · Jun 30, 2024 −$29.78M
Stockholders Equity Q2 2026 · Mar 31, 2024 −$31.47M
Current Liabilities Q2 2026 · Sep 30, 2025 $23.61M
Current Liabilities Q2 2026 · Mar 31, 2025 $20.64M
Total Liabilities Q2 2026 · Sep 30, 2025 $37.98M
Total Liabilities Q2 2026 · Mar 31, 2025 $35.66M
Current Assets Q2 2026 · Sep 30, 2025 $5.54M
Current Assets Q2 2026 · Mar 31, 2025 $4.64M
Total Assets Q2 2026 · Sep 30, 2025 $6.32M
Total Assets Q2 2026 · Mar 31, 2025 $5.64M
Eps Diluted Q2 2026 · Sep 30, 2025 −$0.03
Eps Diluted Q2 2026 · Sep 30, 2025 −$0.06
Eps Diluted Q2 2026 · Sep 30, 2024 −$0.07
Eps Diluted Q2 2026 · Sep 30, 2024 −$0.47
Eps Basic Q2 2026 · Sep 30, 2025 −$0.03
Eps Basic Q2 2026 · Sep 30, 2025 −$0.06
Eps Basic Q2 2026 · Sep 30, 2024 −$0.07
Eps Basic Q2 2026 · Sep 30, 2024 −$0.47
Sga Expense Q2 2026 · Sep 30, 2025 $2.3M
Sga Expense Q2 2026 · Sep 30, 2025 $4.44M
Sga Expense Q2 2026 · Sep 30, 2024 $2.25M
Sga Expense Q2 2026 · Sep 30, 2024 $5.21M
Rd Expense Q2 2026 · Sep 30, 2025 $602.8K
Rd Expense Q2 2026 · Sep 30, 2025 $1.3M
Rd Expense Q2 2026 · Sep 30, 2024 $517.98K
Rd Expense Q2 2026 · Sep 30, 2024 $1.03M
Net Income Q2 2026 · Sep 30, 2025 −$690.91K
Net Income Q2 2026 · Sep 30, 2025 −$1.36M
Net Income Q2 2026 · Sep 30, 2024 −$1.56M
Net Income Q2 2026 · Sep 30, 2024 −$5.26M
Operating Income Q2 2026 · Sep 30, 2025 $273.82K
Operating Income Q2 2026 · Sep 30, 2025 $555.76K
Operating Income Q2 2026 · Sep 30, 2024 −$307.67K
Operating Income Q2 2026 · Sep 30, 2024 −$1.42M
Gross Profit Q2 2026 · Sep 30, 2025 $3.18M
Gross Profit Q2 2026 · Sep 30, 2025 $6.3M
Gross Profit Q2 2026 · Sep 30, 2024 $2.46M
Gross Profit Q2 2026 · Sep 30, 2024 $4.82M
Cost Of Revenue Q2 2026 · Sep 30, 2025 $704.3K
Cost Of Revenue Q2 2026 · Sep 30, 2025 $1.46M
Cost Of Revenue Q2 2026 · Sep 30, 2024 $807.67K
Cost Of Revenue Q2 2026 · Sep 30, 2024 $1.65M
Revenue Q2 2026 · Sep 30, 2025 $3.89M
Revenue Q2 2026 · Sep 30, 2025 $7.76M
Revenue Q2 2026 · Sep 30, 2024 $3.27M
Revenue Q2 2026 · Sep 30, 2024 $6.47M